On the diagnostic front,the clinically approved radiolabeled small-molecule peptide ligand[68Ga]-PSMA-11 (Gallium Ga-68 gozetotide; Illuccix) isextensively used for positron emission tomography (PET) imaging ofPSMA-positive prostate cancer lesions. This evidence concerns the gene FOLH1 and prostate carcinoma.